Cargando…
Neuropeptide Y as Alternative Pharmacotherapy for Antidepressant-Resistant Social Fear
In many social anxiety disorder (SAD) patients, the efficacy of antidepressant therapy is unsatisfactory. Here, we investigated whether mice deficient for the lysosomal glycoprotein acid sphingomyelinase (ASM−/−) represent an appropriate tool to study antidepressant-resistant social fear. We also in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662288/ https://www.ncbi.nlm.nih.gov/pubmed/33153050 http://dx.doi.org/10.3390/ijms21218220 |